Targeted Therapies Driving the European Head and Neck Cancer Therapeutics Markets
26-Sep-2007
New analysis from Frost & Sullivan, European Head and Neck Cancer Therapeutics Markets, reveals that revenues in this market totalled $9.9 million in 2006, and are likely to reach $171.5 million in 2013.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.